You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours

  • Technology appraisal guidance
  • Reference number: TA488
  • Published:  15 November 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Invitation to participate
  4. Draft scope documents

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 224 KB)

    Published:
    15 November 2017

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 332 KB)

    Published:
    12 October 2017
  • Committee papers (PDF 26.75 MB)

    Published:
    12 October 2017
  • Public committee slides Clinical (PDF 536 KB)

    Published:
    12 October 2017
  • Public committee slides Cost (PDF 355 KB)

    Published:
    12 October 2017

Invitation to participate

  • Final scope (PDF 215 KB)

    Published:
    26 January 2017
  • Final matrix (PDF 256 KB)

    Published:
    26 January 2017
  • NICE's response to comments on the draft scope and provisional matrix (PDF 251 KB)

    Published:
    26 January 2017
  • Equality impact assessment (Scoping) (PDF 173 KB)

    Published:
    26 January 2017

Draft scope documents

  • Draft scope (pre-referral) (PDF 258 KB)

    Published:
    26 January 2017
  • Provisional matrix (pre-referral) (PDF 256 KB)

    Published:
    26 January 2017
Back to top